CJC-1295 No DAC 5mg

CJC-1295 No DAC is a modified GHRH(1–29) analogue with four amino acid substitutions enhancing DPP-IV resistance, without the albumin-binding DAC modification. The ~30-minute half-life mimics endogenous pulsatile GHRH signalling more closely than the long-acting DAC variant — ideal for acute GH pulse research.

• Physiologically relevant pulse kinetics — ~30 min half-life enables study of episodic, acute GH release.
• DPP-IV resistance — four stabilising substitutions extend stability versus native GHRH(1–29).
• Synergistic with GHSR agonists — widely combined with Ipamorelin for dual-pathway GH release amplification.
• Well-characterised safety profile — no significant interference with cortisol, prolactin, or thyroid hormones.

⚠️ For research use only. Not for human or animal consumption. Store at −20°C. Reconstitute with Bacteriostatic Water.